Department of Surgery, Duke Children's Hospital and Duke University School of Medicine, Durham, NC, USA.
Pediatr Crit Care Med. 2013 Jun;14(5 Suppl 1):S3-6. doi: 10.1097/PCC.0b013e318292dca5.
For children with severe heart failure in whom medical management has failed, mechanical circulatory support in the form of either extracorporeal membrane oxygenation or ventricular assist device represents life-sustaining therapy. This review provides an overview of these two modalities, including a discussion of indications, contraindications, timing, and device selection, as part of the Pediatric Cardiac Intensive Care Society/Extracorporeal Life Support Organization Joint Statement on Mechanical Circulatory Support. DATA SOURCES, STUDY SELECTION, DATA EXTRACTION: PubMed was searched using the following terms: ECMO, extracorporeal membrane oxygenation, ventricular assist device, VAD, and pediatric. Case reports, single-center series, multicenter studies, and registry reports were reviewed.
The two technologies have unique advantages and disadvantages and may be considered complementary devices, although they are frequently used in sequence. Either modality may be used as bridge-to-transplant or bridge-to-recovery, and the choice of device and device timing is influenced by the acuity of illness, comorbidities, potential for recovery, and anticipated duration of support.
对于药物治疗无效的重症心力衰竭患儿,体外膜氧合或心室辅助装置等机械循环支持代表着维持生命的治疗方法。本综述概述了这两种方式,包括适应证、禁忌证、时机和设备选择的讨论,这是儿科心脏重症监护学会/体外生命支持组织关于机械循环支持的联合声明的一部分。
数据来源、研究选择、数据提取:使用以下术语在 PubMed 上进行搜索:ECMO、体外膜氧合、心室辅助装置、VAD 和儿科。综述了病例报告、单中心系列、多中心研究和注册报告。
结论:这两种技术各有优缺点,可被视为互补设备,尽管它们经常按顺序使用。这两种方式都可作为移植前桥接或恢复前桥接,设备的选择和设备时机受疾病严重程度、合并症、恢复潜力和预期支持时间的影响。